
$11.1B+10% YoYFY 2023
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $11.1B in 2023, compounding +16% a year since 2020 though the pace has cooled. The trailing twelve months are already running at $12.8B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
$40M−21% YoYFY 2023
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $40M in 2023, against $50M the year before. Earnings per share moved -36% over the last twelve months. Trailing twelve-month profit stands at $255M.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
+10.2%revenue growth, FY 2023
→Revenue grew +10% in 2023 against a five-year average of +72%. Earnings went the other way (-21%) even as sales grew, so margins compressed: costs rose faster than revenue.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
$343M+187% YoYFY 2023
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $343M in 2023, compounding +454% a year since 2020. That is the most cash the business has ever thrown off in a year. The trailing twelve months stand at $585M.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→Of $11.1B in 2023 sales, $40M reaches net profit - 0 cents on the dollar. The largest single deduction is producing the product ($8.0B).
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→3 cents of every sales dollar became free cash in 2023, up 3 points since 2020 - the best conversion in its filed history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
◌ 2026 = trailing twelve months to the latest filed quarter (2026-05-03), not a full fiscal year
→The biggest claim on each sales dollar is stock compensation, at 2% of revenue (capital spending 1%). That share has risen since 2020, so the cost of competing is climbing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
◌ 2026 = trailing twelve months to the latest filed quarter (2026-05-03), not a full fiscal year
→Operating margin has held near -0% since 2020. After everything, 0 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
◌ 2026 = trailing twelve months to the latest filed quarter (2026-05-03), not a full fiscal year
→ROE of 60% sits well above ROCE of -2%. A meaningful share of the shareholder return is manufactured with leverage rather than operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
40.1xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 0.8x sales, the market is paying 76% less than CHWY's own 4-year median of 3.2x. Pessimism is priced in - the question is whether it is deserved.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
6.0%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 6.0% of annual free cash flow, more than its 4-year median of 0.7% - the cash is cheaper than usual.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→Debt isn't clearly tagged in CHWY's filings, so treat the balance sheet with extra care rather than assuming zero.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→The company's own capital shrank from $510M in 2023 to $424M (-17%). Buybacks or losses are drawing the buffer down - the distinction matters.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→The share count grew 1.0% in 2023, averaging 2.0% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→CHWY's return on capital is negative at -2.2% in 2023. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→CHWY issued +6% more shares from 2020 to 2023, but revenue per share still rose +47%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03
→Insiders sold $4M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 50 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-05-03